Literature DB >> 6838215

Carnitine octanoyltransferase of mouse liver peroxisomes: properties and effect of hypolipidemic drugs.

S O Farrell, L L Bieber.   

Abstract

Carnitine octanoyltransferase (COT) in 500g supernatant fluids from mouse liver has a specific activity at least twice that of carnitine acetyltransferase (CAT) or carnitine palmitoyltransferase (CPT). When mice are fed diets containing the lipid-lowering drugs, clofibrate or nafenopin, the specific activity of COT increases 4- and 11-fold, respectively. Liver homogenates from mice fed a control diet, and diets containing clofibrate, nafenopin, or Wy-14,643 were fractionated by sucrose gradient centrifugation, and the subcellular distribution of carnitine acyltransferases was determined. In the controls, peroxisomes contained about 70% of the total COT. The specific activity of COT in the peroxisomal peak was 12-fold greater than either CAT or CPT, and 20-fold greater than the COT activity in the mitochondrial fraction. Treatment with hypolipidemic drugs increased the specific activity of peroxisomal COT 2- to 3-fold and CAT 6- to 12-fold, while mitochondrial COT increased 5- to 11-fold and CAT 19- to 54-fold. COT was purified to homogeneity from livers of mice treated with Wy-14,643. It had an apparent Mr of 60,000 by Sephadex G-100 and sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis, and a maximum activity for octanoyl-CoA with acetyl-CoA and palmitoyl-CoA having activities of 2 and 10%, respectively, when 100 microM acyl-CoA substrates were used. The Km's for 1-carnitine, octanoyl-CoA, palmitoyl-CoA, and acetyl-CoA were 130, 15, 69, and 155 microM, respectively, in the forward direction; and in the reverse direction were 110, 100, 104, and 783 microM for CoASH, octanoylcarnitine, palmitoylcarnitine, and acetylcarnitine, respectively. With Vmax conditions, acetyl-CoA and palmitoyl-CoA had activities of 8 and 26% of the activity for octanoyl-CoA, and acetylcarnitine and palmitoylcarnitine had activities of 7 and 22%, respectively, of the activity for octanoylcarnitine. It is concluded that COT is a separate enzyme present in large amounts in the matrix of mouse liver peroxisomes, with kinetic properties that greatly favor medium-chain acylcarnitine formation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6838215     DOI: 10.1016/0003-9861(83)90509-x

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  12 in total

Review 1.  Role of insulin in hepatic fatty acid partitioning: emerging concepts.

Authors:  V A Zammit
Journal:  Biochem J       Date:  1996-02-15       Impact factor: 3.857

Review 2.  The inborn errors of peroxisomal beta-oxidation: a review.

Authors:  R J Wanders; C W van Roermund; R B Schutgens; P G Barth; H S Heymans; H van den Bosch; J M Tager
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  L-carnitine acyltransferase in intact peroxisomes is inhibited by malonyl-CoA.

Authors:  J P Derrick; R R Ramsay
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

Review 4.  Metabolic interactions between peroxisomes and mitochondria with a special focus on acylcarnitine metabolism.

Authors:  Sander M Houten; Ronald J A Wanders; Pablo Ranea-Robles
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-02-10       Impact factor: 5.187

5.  Peroxisomes can oxidize medium- and long-chain fatty acids through a pathway involving ABCD3 and HSD17B4.

Authors:  Sara Violante; Nihad Achetib; Carlo W T van Roermund; Jacob Hagen; Tetyana Dodatko; Frédéric M Vaz; Hans R Waterham; Hongjie Chen; Myriam Baes; Chunli Yu; Carmen A Argmann; Sander M Houten
Journal:  FASEB J       Date:  2018-12-12       Impact factor: 5.191

6.  The facC gene of Aspergillus nidulans encodes an acetate-inducible carnitine acetyltransferase.

Authors:  C J Stemple; M A Davis; M J Hynes
Journal:  J Bacteriol       Date:  1998-12       Impact factor: 3.490

7.  Chlorpromazine and carnitine-dependency of rat liver peroxisomal beta-oxidation of long-chain fatty acids.

Authors:  J Vamecq
Journal:  Biochem J       Date:  1987-02-01       Impact factor: 3.857

8.  Malonyl-CoA inhibition of peroxisomal carnitine octanoyltransferase.

Authors:  N N A'Bháird; R R Ramsay
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

9.  Peroxisomal fatty acid oxidation and inhibitors of the mitochondrial carnitine palmitoyltransferase I in isolated rat hepatocytes.

Authors:  C Skorin; C Necochea; V Johow; U Soto; A M Grau; J Bremer; F Leighton
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

10.  Co-ordinate induction of hepatic mitochondrial and peroxisomal carnitine acyltransferase synthesis by diet and drugs.

Authors:  P S Brady; K A Marine; L J Brady; R R Ramsay
Journal:  Biochem J       Date:  1989-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.